JPRN-jRCT2080221631未知2 期
Pharmacokinetic study of HP-3000 in patients with Parkinson's disease.
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Patients diagnosed with Parkinson's disease in stages 1 to 4 on the modified Hoehn & Yahr scale
排除标准
- •- Patients with a history of hypersensitivity to ropinirole
- •- Patients with clinically significant renal impairment or hepatic dysfunction
- •- Patients with skin disease at the application site for the investigational drug that may hinder its evaluation or patients receiving any treatment that may interfere with evaluation of the drug
研究者
相似试验
未知
2 期
Phase II clinical study in patients with idiopathic restless legs syndrome.Idiopathic restless legs syndromeJPRN-jRCT2080222232Hisamitsu Pharmaceutical Co., Inc.
未知
2 期
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.Cancer painJPRN-jRCT2080222905Hisamitsu Pharmaceutical Co., Inc
未知
3 期
ong-term study of HP-3000 in patients with Parkinson's diseaseParkinson's diseaseJPRN-jRCT2080222696Hisamitsu Pharmaceutical Co.,Inc.
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
未知
1 期
Phase I/II study of HP-3060 in patients with allergic rhinitis.Allergic rhinitisJPRN-jRCT2080222141Hisamitsu Pharmaceutical Co., Inc.